1. Home
  2. BRBS vs EBS Comparison

BRBS vs EBS Comparison

Compare BRBS & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BRBS

Blue Ridge Bankshares Inc.

N/A

Current Price

$3.97

Market Cap

392.4M

Sector

Finance

ML Signal

N/A

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

N/A

Current Price

$8.09

Market Cap

434.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BRBS
EBS
Founded
1893
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
392.4M
434.4M
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
BRBS
EBS
Price
$3.97
$8.09
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
234.7K
1.0M
Earning Date
01-01-0001
05-27-2026
Dividend Yield
6.31%
N/A
EPS Growth
88.64
125.83
EPS
0.07
0.93
Revenue
$111,284,000.00
$742,900,000.00
Revenue This Year
N/A
$29.50
Revenue Next Year
N/A
N/A
P/E Ratio
$56.57
$8.80
Revenue Growth
123.99
N/A
52 Week Low
$2.92
$4.02
52 Week High
$4.79
$14.06

Technical Indicators

Market Signals
Indicator
BRBS
EBS
Relative Strength Index (RSI) 34.30 28.26
Support Level $3.37 $7.66
Resistance Level $4.10 $9.68
Average True Range (ATR) 0.11 0.54
MACD -0.01 -0.13
Stochastic Oscillator 16.87 7.40

Price Performance

Historical Comparison
BRBS
EBS

About BRBS Blue Ridge Bankshares Inc.

Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance and others. It has three reportable business segments: commercial banking, mortgage banking, and holding company activities.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: